CD4 and cancer: These findings also bring to the forefront the attractive possibility of utilizing the phenotypic plasticity of cancer cells along with CD73 and CD4+ T cells as a predictive criterion for immunotherapy responsiveness.<h4>Significance</h4>EMP enables metastasis and drives resistance to multiple treatment regimens.